## WTW: Willis Towers Watson Public Lim - XLF: Financial Services

### Executive Summary

No thesis match: PEG 1.08 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($314.63)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. WTW Outperforms Industry, Trades at a Discount: Time to Hold?**
- Source: The Globe and Mail | 20251211T030855 | Somewhat-Bullish | Relevance: 100%
- Willis Towers Watson Public Limited Company (WTW) shares have outperformed the industry and are trading at a discount, with favorable growth projections and analyst sentiment. Despite rising expenses and a relatively weak ROE compared to the industry, WTW's strong product portfolio, strategic acquisitions, and robust capital position suggest a "Hold" rating. Investors should be cautious due to increased expenses and a lower return on equity compared to peers.

**2. WTW Outperforms Industry, Trades at a Discount: Time to Hold?**
- Source: The Globe and Mail | 20251210T200851 | Bullish | Relevance: 100%
- Willis Towers Watson (WTW) has outperformed its industry, gaining 4.8% in the past year while the industry declined 27.4%. The company trades at a discount compared to the Zacks Brokerage Insurance industry and shows encouraging growth projections for 2026. Despite rising expenses and a lower return on equity compared to the industry average, WTW maintains a strong capital position and a robust product portfolio, leading to a "Hold" rating from Zacks.

**3. WTW Outperforms Industry, Trades at a Discount: Time to Hold?**
- Source: TradingView | 20251210T150831 | Somewhat-Bullish | Relevance: 100%
- Willis Towers Watson (WTW) has outperformed its industry, gaining 4.8% in the past year, while trading at a discount compared to its industry average. Despite strong growth projections, strategic acquisitions, and a robust capital position, rising expenses and a weak return on equity suggest a cautious approach. The stock currently holds a Zacks Rank #3 (Hold).

**4. Willis Towers Watson Public Limited Company agreed to acquire Newfront Insurance Holdings, Inc. for $1.4 billion.**
- Source: marketscreener.com | 20251210T125329 | Bullish | Relevance: 100%
- Willis Towers Watson Public Limited Company (WTW) has agreed to acquire Newfront Insurance Holdings, Inc. for $1.4 billion. The consideration includes $900 million in cash and $150 million in WTW common equity, along with a $400 million contingent payment also in common equity. The acquisition, set to close in the first quarter of 2026, has been approved by WTW's board and is subject to regulatory approval.

**5. Keefe, Bruyette & Woods Maintains Willis Towers Watson Public Limited (WTW) Outperform Recommendation**
- Source: Nasdaq | 20251213T000859 | Bullish | Relevance: 100%
- Keefe, Bruyette & Woods has reiterated an Outperform recommendation for Willis Towers Watson Public Limited (WTW). The average one-year price target for WTW is $371.27, suggesting a 13.56% upside from its current price. Institutional ownership in WTW shows varying movements, with some firms like Harris Associates L P and Dodge & Cox increasing their stakes significantly.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Wells Fargo | $356 | $362 | -2% |
| 2025-12-12 | Keefe, Bruyette | $375 | $373 | +1% |
| 2025-11-20 | Barclays | $303 | $341 | -11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Wells Fargo | main | Overweight |
| 2025-12-12 | Keefe, Bruyette | main | Outperform |
| 2025-11-20 | Barclays | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 27 ($0.23M) |
| Sells | 7 ($0.24M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.9%)
- Blackrock Inc.: 9.7% (-4.7%)
- Massachusetts Financ: 6.5% (-0.9%)
- Harris Associates L.: 4.5% (+13.4%)
- State Street Corpora: 4.5% (-0.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +4.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.08 suggests fair value with growth premium. Quality metrics strong (ROE 28%, margin 22%). Analyst sentiment negative (2 target cuts vs 1 raises). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $31.9B |
| Beta | 0.64 |
| 52W Range | $292.97 - $352.79 |
| Short Interest | 3.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.08 |
| Forward P/E | 16.9 |
| Current P/E | 19.3 |
| YoY Growth | 13.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.7% to 3.3% (+4.0% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 67th percentile. MRS_5 at 2.9% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.16), confirming momentum. RSI neutral at 57. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.29% (CS: 68) | Strong |
| RSI_14 | 57.1 | Neutral |
| MACD Histogram | 1.16 | Bullish |
| vs SMA20 | 1.023x | Above |
| vs SMA50 | 1.004x | Above |
| vs SMA200 | 1.018x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $326.93
- **Stop Loss:** $314.63 (3.8% risk)
- **Target:** $339.23 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 97
- **Position Value:** $31,712.21
- **Portfolio %:** 31.71%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-05 (Est: $7.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.05 | $3.07 | +0.7% |
| 2025Q2 | $2.60 | $2.86 | +10.2% |
| 2025Q1 | $3.19 | $3.13 | -1.8% |
| 2024Q4 | $8.03 | $8.13 | +1.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*